Journal article
Animal and model systems for studying cystic fibrosis
Journal of cystic fibrosis, Vol.17(2), pp.S28-S34
03/2018
DOI: 10.1016/j.jcf.2017.09.001
PMCID: PMC5828943
PMID: 28939349
Abstract
The cystic fibrosis (CF) field is the beneficiary of five species of animal models that lack functional cystic fibrosis transmembrane conductance regulator (CFTR) channel. These models are rapidly informing mechanisms of disease pathogenesis and CFTR function regardless of how faithfully a given organ reproduces the human CF phenotype. New approaches of genetic engineering with RNA-guided nucleases are rapidly expanding both the potential types of models available and the approaches to correct the CFTR defect. The application of new CRISPR/Cas9 genome editing techniques are similarly increasing capabilities for in vitro modeling of CFTR functions in cell lines and primary cells using air-liquid interface cultures and organoids. Gene editing of CFTR mutations in somatic stem cells and induced pluripotent stem cells is also transforming gene therapy approaches for CF. This short review evaluates several areas that are key to building animal and cell systems capable of modeling CF disease and testing potential treatments.
Details
- Title: Subtitle
- Animal and model systems for studying cystic fibrosis
- Creators
- Bradley H Rosen - Department of Anatomy & Cell Biology, Carver College of Medicine at the University of Iowa, Iowa City, IA 52242, USAMarc Chanson - Department of Pediatrics, Faculty of Medicine at the University of Geneva, SwitzerlandLara R Gawenis - Dalton Cardiovascular Research Center at the University of Missouri, Columbia, MO 65211, USAJinghua Liu - Dalton Cardiovascular Research Center at the University of Missouri, Columbia, MO 65211, USAAderonke Sofoluwe - Department of Pediatrics, Faculty of Medicine at the University of Geneva, SwitzerlandAlice Zoso - Department of Pediatrics, Faculty of Medicine at the University of Geneva, SwitzerlandJohn F Engelhardt - Department of Anatomy & Cell Biology, Carver College of Medicine at the University of Iowa, Iowa City, IA 52242, USA
- Resource Type
- Journal article
- Publication Details
- Journal of cystic fibrosis, Vol.17(2), pp.S28-S34
- Publisher
- Elsevier B.V
- DOI
- 10.1016/j.jcf.2017.09.001
- PMID
- 28939349
- PMCID
- PMC5828943
- ISSN
- 1569-1993
- eISSN
- 1873-5010
- Grant note
- DOI: 10.13039/100000002, name: National Institutes of Health, award: P30 DK54759, R24HL123482, DK096518; DOI: 10.13039/100000897, name: Cystic Fibrosis Foundation, award: ROSEN17I0, ROSEN17XX0; name: Swiss CF Foundation; DOI: 10.13039/100001935, name: Foundation ABCF; DOI: 10.13039/501100006342, name: Association Vaincre la Mucoviscidose; DOI: 10.13039/501100001711, name: Swiss National Science Foundation, award: 310030_172909/1
- Language
- English
- Date published
- 03/2018
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Pulmonary, Critical Care, and Occupational Medicine; Anatomy and Cell Biology; Radiation Oncology; Internal Medicine
- Record Identifier
- 9984025413602771
Metrics
33 Record Views